May 22, 2022
NASH Platform trial
Vall d’Hebron Institute of Research (VHIR) and the Liver Unit of Vall d’Hebron University Hospital (VHUH) hosted a scientific meeting in Barcelona last May 11th & 12th to discuss the next steps in the development of platform trials for Non-Alcoholic Steatohepatitis (NASH) disease. The meeting brought together academic and industry experts closely collaborating in EU-PEARL...
Read More
Platform Trials
By Sarai Rodríguez Navarro and Joan Genescà (VHIR) EU-PEARL (European Union-Patient-cEntric clinicAl tRial pLatforms), an IMI (Innovative Medicines Initiative)-founded project,  was conceived as a means to change the paradigm of clinical trials in Europe, by promoting more adaptive, efficient and patient-centered clinical trials, thus contributing to accelerate drug development and the access to new and...
Read More

Sign up to stay informed

    We will process your data to deliver our quarterly updates to your inbox. You can view our Privacy Policy here or contact us at